➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Boehringer Ingelheim
AstraZeneca
Moodys
McKinsey

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

Alkem Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ALKEM, and what generic and branded alternatives to ALKEM drugs are available?

ALKEM has sixty-eight approved drugs.

There are twelve tentative approvals on ALKEM drugs.

Summary for Alkem
US Patents:0
Tradenames:55
Ingredients:55
NDAs:68
Patent Litigation for Alkem: See patent lawsuits for Alkem

Drugs and US Patents for Alkem

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alkem GABAPENTIN gabapentin CAPSULE;ORAL 090858-002 Dec 17, 2010 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd COLCHICINE colchicine TABLET;ORAL 211250-001 Feb 8, 2019 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065496-002 Jun 7, 2010 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd EZETIMIBE AND SIMVASTATIN ezetimibe; simvastatin TABLET;ORAL 209222-004 Dec 22, 2017 AB RX No No   Start Trial   Start Trial
Alkem Labs Ltd QUETIAPINE FUMARATE quetiapine fumarate TABLET;ORAL 201504-005 Feb 12, 2013 AB RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Alkem

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-001 May 31, 1985 6,703,418   Start Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-003 May 31, 1985 6,703,418   Start Trial
Alkem Labs Ltd MARINOL dronabinol CAPSULE;ORAL 018651-002 May 31, 1985 6,703,418   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKinsey
Harvard Business School
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.